Last reviewed · How we verify

Methadone; NAC — Competitive Intelligence Brief

Methadone; NAC (Methadone; NAC) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid agonist with antioxidant adjunct. Area: Pain Management, Substance Use Disorder.

marketed Opioid agonist with antioxidant adjunct Mu opioid receptor (methadone); glutathione synthesis pathway (NAC) Pain Management, Substance Use Disorder Small molecule Live · refreshed every 30 min

Target snapshot

Methadone; NAC (Methadone; NAC) — Taichung Veterans General Hospital. Methadone is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system, while NAC (N-acetylcysteine) is an antioxidant that replenishes glutathione and may modulate opioid-related neurotoxicity.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Methadone; NAC TARGET Methadone; NAC Taichung Veterans General Hospital marketed Opioid agonist with antioxidant adjunct Mu opioid receptor (methadone); glutathione synthesis pathway (NAC)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid agonist with antioxidant adjunct class)

  1. Taichung Veterans General Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Methadone; NAC — Competitive Intelligence Brief. https://druglandscape.com/ci/methadone-nac. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: